[1] Gupta AR, Shah NR, Patel TC, et al. Perioperative and long-term complications of iliac crest bone graft harvesting for spinal surgery: a quantitative review of the literature [J]. Int Med J, 2001,8(9):63-66. [2] Boden SD, Titus L, Hair G, et al. Lumbar spine fusion by local gene therapy with cDNA encoding a novel osteoinductive protein (LMP-1) [J].Spine,1998,23(23):2486-2492. [3] Lawrence JP, Ennis F, White AP, et al. Effect of daily parathyroid hormone (1-34) on lumbar fusion in a rat model [J].Spine, 2006, 6(4):385-390. [4] Abe Y, Takahata M, Ito M, et al. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1–34) in a rat spinal arthrodesis model [J].Bone, 2007,41(5):775-785. [5] Huang RC, Khan SN, Sandhu HS, et al. Alendronate inhibits spine fusion in a rat model [J].Spine,2005,30(22):2516-2522. [6] Grauer JN, Bomback DA, Lugo R, et al. Posterolateral lumbar fusions in athymic rats:characterization of a model [J]. Spine,2004,4(3):281-286. [7] O'Loughlin PF, Cunningham ME, Bukata SV, et al. Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model [J]. Spine,2009,34(2):121-130. [8] Grauer JN, Patel TC, Erulkar JS, et al. Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion [J]. Spine,2001,26(2):127-133. [9] Steinmann JC, Herkowitz N. Pseudarthosis of the spine [J].Clin Orthop,1992,(284):80-90. [10]Boden SD, Schimandle JH, Hutton WC. An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics [J]. Spine,1995,20(4):412-420.
|